Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Working Capital Changes (2016 - 2021)

Historic Other Working Capital Changes for Neurocrine Biosciences (NBIX) over the last 12 years, with Q4 2021 value amounting to -$12.5 million.

  • Neurocrine Biosciences' Other Working Capital Changes rose 6044.3% to -$12.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $9.2 million, marking a year-over-year increase of 14864.86%. This contributed to the annual value of $24.5 million for FY2024, which is 15125.52% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Other Working Capital Changes stood at -$12.5 million for Q4 2021, which was up 6044.3% from $16.1 million recorded in Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Other Working Capital Changes registered a high of $31.2 million during Q3 2020, and its lowest value of -$31.6 million during Q4 2020.
  • For the 5-year period, Neurocrine Biosciences' Other Working Capital Changes averaged around $562750.0, with its median value being $163500.0 (2017).
  • Per our database at Business Quant, Neurocrine Biosciences' Other Working Capital Changes plummeted by 659767.44% in 2017 and then skyrocketed by 350000.0% in 2020.
  • Quarter analysis of 5 years shows Neurocrine Biosciences' Other Working Capital Changes stood at -$5.8 million in 2017, then soared by 70.24% to -$1.7 million in 2018, then soared by 753.44% to $11.2 million in 2019, then tumbled by 382.14% to -$31.6 million in 2020, then surged by 60.44% to -$12.5 million in 2021.
  • Its Other Working Capital Changes was -$12.5 million in Q4 2021, compared to $16.1 million in Q3 2021 and $3.0 million in Q2 2021.